Exogenesis nanoMesh

Exogenesis nanoMesh is a medical-device business within Exogenesis focused on commercializing nanoMesh, a soft tissue repair implant for hernia repair. The product is a monofilament polypropylene mesh treated with Exogenesis's Accelerated Neutral Atom Beam (ANAB) technology to create a nanometer-scale surface texture intended to improve tissue integration and reduce inflammatory response. Public company materials describe first-in-man implantation in 2021, expansion of the product line, and planned U.S. commercialization. The business appears to operate as nanoMesh LLC, a subsidiary of Exogenesis Corporation, rather than as an independent therapeutics developer. It is healthcare-related, but better classified as a surgical implant/device company than a biotech or pharma company.